Wednesday April 1, 2020

€200m pharma plan for Cork frozen by Trump fears

Project stalled as Eli Lilly awaits further information about new president's plans for industry

12th February, 2017

Pharmaceutical giant Eli Lilly has delayed a €200 million investment in Cork amid fears of a clampdown on the pharmaceutical sector by the newly elected US president Donald Trump.

A number of sources in Cork have confirmed to The Sunday Business Post that the project has been stalled as Eli Lilly awaits further information about Trump’s plans for its industry.

The new investment would create hundreds of jobs.

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

Every time Donald Trump spoke on the Covid-19 crisis last week, the stock markets plunged by another point

Marion McKeone | 2 weeks ago

Big tech firms pledge to pay contract staff through the social-distancing period

Emmet Ryan | 2 weeks ago

Further action may be needed to prevent the Irish economy being sunk, particularly when the global economy remains vulnerable

Ian Guider | 2 weeks ago